Showing results (11-20 of 19) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
The Journal of Investigative Dermatology|December 14, 1999
Differential regulation of epidermal and dermal dendritic cells by IL-12 and Flt3 ligandC Esche, V M Subbotin, O Hunter, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2001
Tumor necrosis factor-alpha-promoted expression of Bcl-2 and inhibition of mitochondrial cytochrome c release mediate resistance of mature dendritic cells to melanoma-induced apoptosisC Esche, G V Shurin, J M Kirkwood, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 5, 2000
Transduction of dendritic cells with Bcl-xL increases their resistance to prostate cancer-induced apoptosis and antitumor effect in miceG Pirtskhalaishvili, G V Shurin, A Gambotto, et al.Journal of Neuroimmunology|June 30, 2001
Identification of delta- and mu-type opioid receptors on human and murine dendritic cellsV P Makarenkova, C Esche, N V Kost, et al.European Journal of Immunology|July 31, 1999
CD154 inhibits tumor-induced apoptosis in dendritic cells and tumor growthC Esche, A Gambotto, Y Satoh, et al.British Journal of Cancer|August 17, 2000
Cytokine-mediated protection of human dendritic cells from prostate cancer-induced apoptosis is regulated by the Bcl-2 family of proteinsG Pirtskhalaishvili, G V Shurin, C Esche, et al.Journal of Leukocyte Biology|August 17, 1999
Tumor's other immune targets: dendritic cellsC Esche, A Lokshin, G V Shurin, et al.Human Genetics|December 1, 1996
Is the mismatch repair deficient type of Muir-Torre syndrome confined to mutations in the hMSH2 gene?R Kruse, C Lamberti, Y Wang, et al.The Cancer Journal From Scientific American|February 24, 2000
Interleukin-2: developing additional cytokine gene therapies using fibroblasts or dendritic cells to enhance tumor immunityM T Lotze, M Shurin, C Esche, et al.Pageof 2